https://www.selleckchem.com/pr....oducts/prt062607-p50
15, 95%CI0.64-2.04). The post-discharge survival for HLH was 33% for TS and 51% for non-syndromic patients, with these numbers being too small for meaningful comparisons. There was a higher risk for cardiovascular disease (CVD) events in patients with TS vs. male (aHR 3.72, 95%CI1.64-8.39) and female comparators (aHR 4.55, 95%CI1.87-11.06) excluding heart-failure deaths. The 30-year transplant-free survival is similar for patients with TS and non-syndromic comparators with operated two-ventricle LHOL without excess CHD ris
Like
Comment
Share
